Director James McConville receives 5,294 YSS (YSS) restricted stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Yellowstone Midco Holdings II, LLC director James McConville received an equity grant in the form of restricted stock units. On 01/30/2026, he was awarded 5,294 shares of common stock at a price of $0 per share. These units vest on the first anniversary of the grant date. Following this award, he beneficially owns 5,294 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
McConville James
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,294 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 5,294 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did YSS director James McConville report?
James McConville reported receiving 5,294 shares of Yellowstone Midco Holdings II, LLC common stock as an equity grant. The award was filed as a Form 4 insider transaction dated January 30, 2026, and is recorded as an acquisition at a price of $0 per share.
What type of securities did James McConville acquire in YSS?
James McConville acquired restricted stock units representing 5,294 shares of Yellowstone Midco Holdings II, LLC common stock. These units convert into common shares, giving him direct beneficial ownership once vested, and were granted at no cash cost to him per share.
When do James McConville’s YSS restricted stock units vest?
The restricted stock units granted to James McConville vest on the first anniversary of the grant date. Since the grant date is January 30, 2026, the units are scheduled to vest one year later, assuming any applicable service or other vesting conditions are satisfied.
Is James McConville a director or officer of Yellowstone Midco Holdings II, LLC (YSS)?
James McConville is identified as a director of Yellowstone Midco Holdings II, LLC. The Form 4 checkboxes show his status as a director and do not indicate any officer role or 10% beneficial ownership position in the company’s equity.